BCL2 and pancreatic neoplasm: Investigation on pancreatic cancer showed that some Bcl-XL (an anti-apoptotic factor of the Bcl-2 family) sequence-specific antisense oligonucleotides could suppress pancreatic tumor growth and sensitize tumor cells to gemcitabine [49].